TugceD
@TugcesTweeting
Followers
47
Following
104
Media
12
Statuses
67
Regular tweet-reader | Neuroscience PhD |
Joined September 2015
3 new pubs out of our group!
3 new early-career @WFADRC pubs: @sudkrish w/a case on prion disease in mixed dem https://t.co/B5onOoc8Vw;
@TugcesTweeting validated a remote/UDSv4-friendly PACC; https://t.co/se1wqmJcLT;
@brettmfrye examined how Med diet in NHP may be neuroprotective!
1
1
8
Congratulations to @TugcesTweeting who successfully defended her PhD Dissertation recently!!! She is going to be moving on to a postdoc at the National Institute on Aging. We can’t wait to see all the amazing work you’ll do at the NIH, Tugce! 🎉
1
4
14
🌍WORLD VIEW: Jamie Justice introduces the XPRIZE Healthspan, a 7-year global competition to develop gerotherapeutics, and invites the community to shape the 1st phase of the competition @j_n_justice @xprize @hevolution_f @SOLVEFSHD
https://t.co/WdNbmM0VBs
nature.com
Nature Aging - The $101 million XPRIZE Healthspan is a 7-year global competition to catalyze the development of interventions to restore function lost to age-related decline of multiple organ...
4
10
44
📣 Postdoc position!! If you are curious about novel synaptic biomarkers and PET-tracer UCBJ then we are looking for you! Perks: Great team, free entry to noble lectures and fika in beautiful Stockholm 🎉 please RT and share with your network!
ki.varbi.com
Do you want to contribute to top quality medical research? The postdoctoral position is for lab (experimental) based research and the postdoctoral fellow will be working with Dr. Amit Kumar in the �
0
2
11
Work from @WakeADC: hypertension & its co-occurrence w/impaired glucose tolerance assoc. w/lower cognitive performance, reduced cerebral perfusion, & impaired white matter microstructure. https://t.co/aRx6G3UdyY
@fishTMH @bonnie_sachs @RenegadeSynapse @mia_geri28 @WakeGeriatrics
pubmed.ncbi.nlm.nih.gov
HTN and its co-occurrence with IGT (HTN+IGT) were associated with lower global cognitive performance and reduced GM perfusion and impaired WM microstructure.
0
6
10
Work from our lab at the @WakeADC, investigating the impacts of baseline neuroimaging and clinical biomarkers on cognitive migration in a community-dwelling older cohort, is now published in Neuroimage: Clinical!
0
4
8
Got accepted to #BSS2021-Neurepiomics! So excited 🎉
#BSS2021 Last days to apply for the online “Neurepiomics” Bordeaux Summer School, open to graduate and doctoral students, post-doctoral fellows and senior researchers #neuroepidemiology #omics #brainimaging
https://t.co/VAmf8fUD3m
0
0
1
The first Appropriate Use Recommendations for Aducanomab drop amidst heated debates about the FDA accelerated approval devoid of guidance of who and how should be treated. Here is the paper - https://t.co/d18dnftqFq.
@IUMedSchool @NeurosciStark @iadrc_iu @alzassociation
0
13
16
I enjoy reading academic tweets for recent papers in #Alzheimers research! 💜 Is Twitter the new PubMed? #AcademicTwitter
0
0
1
Junior and senior investigators, register, submit abstracts, and lets us fully yet safely embrace networking and great science in November! @_paigely @NeurosciStark @TugcesTweeting @FlahertyRyn @KcD_PhD @EmrinHrgsl @Riedelbc @meichen_yu @DianaSvaldi @AlicePatania @everyxs @mlreid
Lead the way to what's next in neuroscience. We are now accepting abstracts for the first-ever AAIC Neuroscience Next. Neuroscience students and early career investigators are invited to submit by Sept. 21. Learn more: https://t.co/4uXQ9hGB8O.
#AAICNeuro #ENDALZ
1
5
14
A U.K. patient played the violin during her brain tumor surgery. “We knew how important the violin is to Dagmar, so it was vital that we preserved function in the delicate areas of her brain that allowed her to play,” said the violinist's neurosurgeon https://t.co/h3659uLsFR
351
10K
29K
"We are on the verge of something truly transformational. The first survivor of Alzheimer’s disease may be reading this story now," writes Dr. Maria Carrillo. In partnership with #TIME100Health Summit Knowledge Partner @alzassociation
https://t.co/KvfGV87fnF
time.com
Maria Carrillo, the chief science officer of the Alzheimer’s Association, argues that we're on the verge of a new era in treatments.
9
87
206